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Objective: To investigate the value of intraoperative blood flow measurements on early and long-term patency of
above-knee prosthetic femoropopliteal bypass.
Methods: Flow was measured with a transit time flowmeter before (basal flow) and after an intragraft injection of
papaverine (papaverine flow) in 87 operations (86 patients) between January 1990 and December 2001. Sixty-one grafts
were of polyester, and 26 were of polytetrafluoroethylene. The operations were done under epidural anesthesia. The
preoperative angiographic run-off score and clinical risk factors were recorded. Patency rates were analyzed with the
product limit method and compared with the log-rank test. Variables found to be near significantly related to patency
rates (P < .1) were included in a multivariate analysis performed with the Cox proportional hazard model.
Results: Basal flow measurements were not related to patency. The 2- and 5-year patency rates for grafts with a papaverine
flow <500 mL/min were 48% and 18% compared with 66% and 52% for grafts with a papaverine flow >500 mL/min.
These differences were statistically significant (P  .012, hazard ratio, 2.6). Two- and 5-year patency rates for smokers
vs nonsmokers were 44% and 18% vs 69% and 54%. The patency rates for patients with poor vs good run-off were 42% and
27% vs 66% and 31%. Smoking (P .008, hazard ratio, 2.75) and poor run-off score (P .009, hazard ratio, 2.38) were
found to be independent risk factors for reduced patency rates. Poor run-off score did not correlate with low values of
measured basal or papaverine flow.
Conclusions: Papaverine flow of <500 mL/min is associated with reduced mid- and long-term patency rates. Additional
antithrombotic medication and frequent follow-up for these grafts should be considered. The inferior patency rates of
smokers and patients with poor run-off indicate that prosthetic bypass is less suitable for these groups of patients. ( J Vasc
Surg 2006;43:729-34.)Intraoperative flow measurement in infrainguinal by-
pass surgery is used as a dynamic and functional quality
control of vascular reconstructions. Electromagnetic flow-
metry was used until the 1990s, whereas transit time flow-
meters became available during the 1980s. Since then, the
latter method has been widely used. Low values of blood-
flow measurements have been reported to be predictive of
early graft occlusion in infrainguinal bypass surgery.1-5A
flow of 50 mL/min has been associated with failure of
above-knee prostheses.4,5 Lundell and Bergqvist1 reported
a flow of 50 mL/min to predict graft occlusion 3 months
postoperatively in vein grafts, whereas Stirnemann et al5
suggested that vein grafts could remain patent with a flow
of as low as 10 mL/min. Low levels of maximum capacity
flow (ie, the peak flow after intragraft injection of papaver-
ine) have also been reported to be predictive of reduced
graft patency in vein grafts.2
To our knowledge, the relationship between papaver-
ine flow and femoropopliteal prosthetic graft patency has
not previously been reported. The present study investi-
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doi:10.1016/j.jvs.2005.12.041gates the influence of intraoperative flow on graft patency
rates in above-knee prosthetic femoropopliteal bypass. Pa-
tient-related risk factors were also studied for their impact
on graft patency.
PATIENTS AND METHODS
From 1990 through 2001, intraoperative transit time
blood flow measurements were performed in 87 above-
knee prosthetic femoropopliteal bypass operations in 86
patients (57 men and 29 women) at our department.
Sixty-one grafts were of polyester (Unigraft, B Braun,
Melsungen, Germany) and 26 were of polytetrafluoroeth-
ylene (PTFE) (Gore-Tex, W.L. Gore & Associates, Flag-
staff, Ariz). PTFE grafts were used during the first 4 years of
the study period, and polyester grafts were used latterly.
Forty-four of the polyester grafts were impregnated, and 17
were not. The graft diameter was 8 mm in 68 cases and 6
mm in 19 cases. Data were prospectively recorded in a
vascular registry maintained by the department.
The indication for surgery was intermittent claudica-
tion in 48 patients and critical ischemia in 39 (21 with rest
pain, 18 with ulcer or gangrene). Critical ischemia was
defined according to the second European Consensus Doc-
ument on chronic, critical leg ischemia.6 The mean age of
the patients was 67 years for men and 72 years for women.
Preoperative risk factors are summarized in Table I.
The run-off score was defined by the number of patent
crural arteries that were seen on the preoperative angio-
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artery). Run-off score was recorded in 82 patients, of which
39 were classified as poor. In three patients, the angiograms
were missing at the time of the study, and two operations
were performed without a preoperative angiography.
All operations were done under epidural anesthesia.
The surgical technique was uniform, with end-to-side anas-
tomosis between the graft and the native artery in both the
proximal and the distal anastomosis. Heparin (5000 IU)
was administered intravenously before the common femo-
ral artery was clamped. Postoperatively, all patients were
given aspirin (160 mg daily) on a permanent basis, if
tolerated. No other antithrombotic agent was given.
A transit time Doppler flowmeter (CardioMed 1000,
Medi-Stim AS, Oslo, Norway) was used for blood-flow
measurements. The probes were precalibrated by the man-
ufacturer, and the measurement error was 10%. Flow was
measured with the probe placed around the popliteal artery
below the distal anastomosis. Where lack of exposure pro-
hibited flow measurement of the popliteal artery, flow was
measured in the common femoral artery while the profunda
femoral artery was clamped. Flow was measured before and
after a 40-mg intragraft injection of papaverine. The basal
flowwas defined as the flowmeasured before the papaverine
injection, and the maximum flow after the papaverine in-
jection was defined as the papaverine flow.
Follow-up was done after 1, 3, 6, and 12 months, and
annually thereafter with duplex ultrasound examination
and ankle-brachial pressure measurements. The mean and
median graft follow-up was 28 and 21 months (range, 0
to116 months). According to the department’s protocol,
graft-related significant stenoses (50% diameter reduc-
tion) were treated, usually with endovascular techniques.
Graft occlusion was confirmed with either duplex scanning
or angiography. The end point of the study was the primary
occlusion date.
Fisher’s exact test was used for comparison of categoric
data. Primary assisted patency rates were calculated with the
product-limit method and illustrated as Kaplan-Meier
curves. Univariate comparisons of patency were done with
the log-rank test. Variables found to be near significantly
correlated with patency (P  .1) were subjected to multi-
variate analysis performed with the Cox proportional haz-
Table I. The risk factors in 86 patients (87 limbs) who
had records of intraoperative flow measurements
Preoperative risk factors Patients (n)
Hypertension 39
Diabetes mellitus 7
COPD 12
Coronary artery disease 33
Cerebrovascular stroke 6
Serum creatinine 125 mmol/L 7
Smoking 54
COPD, Chronic obstructive pulmonary disease.ard model. The software program SPSS 13.0 (SPSS Inc.Chicago, Ill) for Windows (Microsoft, Redmond, Wash)
was used for statistical computations. Differences were
considered statistically significant at the 5% level (P .05).
RESULTS
The overall primary assisted patency rates were 93% at
30 days, 80% at 6 months, and 76% at 12 months. The 2-
and 5-year patency rates were 52% and 31% (Fig 1). Primary
occlusion was recorded for 46 grafts during follow-up
(53%). One patient was treated with percutaneous translu-
minal angioplasty for a graft-related stenotic lesion. The
30-day mortality was zero. Graft type (PTFE or Polyester)
and graft diameter (6 or 8 mm) did not influence patency.
The mean and median basal flow was 266 and 211
mL/min (range, 52 to 1300). The distribution is illus-
trated in Fig 2. Injection of papaverine increased the value
to a mean of 400 mL/min and a median of 489 mL/min
(range, 120 to 2400 mL/min). The distribution of papav-
erine flow measurements is illustrated in Fig 3.
Basal flow had no association with reduced patency
rates. Papaverine flow levels of 300, 400, 500, and 600
mL/min were analyzed for impact on patency rates. A
papaverine flow of 500 mL/min was significantly associ-
ated with reduced primary assisted patency as calculated by
both univariate (P  .030) and multivariate analyses (P 
.012, hazard ratio, 2.6). A papaverine flow of 500 mL/
min was recorded in 59 patients (68%). The primary as-
sisted patency rates for grafts with papaverine flow 500
mL/min were 89% at 30 days, 69% at 6 months, 58% at
12 months, 48% at 2 years, and 18% at 5 years; for grafts
with papaverine flow of 500 mL/min, the respective
patency rates were 97%, 86%, 83%, 66%, and 52%. The
impact of papaverine flow on graft patency is presented in
Table II and Fig 4.
Flow increase, expressed as papaverine flow/basal flow
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Fig 1. The primary assisted patency rates of 87 above-knee fem-
oropopliteal prostheses. The numbers below the curve indicate the
numbers at risk.and as papaverine flow minus basal flow was then analyzed
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flow increase were analyzed, no association between flow
increase and patency could be found. This was the case for
papaverine flow/basal flow as well as for papaverine flow
minus basal flow.
Smoking caused significantly reduced primary assisted
patency in both univariate (P  .03) and multivariate
analyses (P  .008, hazard ratio, 2.75). The patency rates
and statistic details are given in Tables II and III. There was
a similar distribution of poor run-off scores for smokers and
nonsmokers and for patients with high or low flow (both
basal and papaverine flow), as analyzed with Fisher’s exact
test.
Poor run-off score was not significantly associated with
reduced patency in univariate analysis (P  .090), but
multivariate analysis revealed poor run-off as an indepen-
dent risk factor for reduced graft patency (P .009, hazard
ratio, 2.38). Low papaverine flow was not more frequent
among those with a poor run-off score compared with
those with a good run-off score.
Six grafts occluded during the first postoperative month
(6.9%), and 17 grafts (20%) occluded3 months of surgery.
There were no differences in the distribution of risk factors
or flow measurements between the early occluders and
those that stayed open 3 months by Fisher’s exact test.
The 2- and 5-year patency rates for grafts implanted for
intermittent claudication and with a high papaverine flow
were 68% and 60% vs 60% and 18% for grafts implanted for
intermittent claudication and low papaverine flow. This
difference was statistically significant (P  .043, log-rank
test). The same was tested for intermittent claudication and
run-off, for the combination of intermittent claudication
plus high flow plus good run-off, and for the combination
of intermittent claudication plus high flow plus good run-
Fig 2. The distribution of intraoperative basal flow measure-
ments in 87 above-knee prosthetic femoropopliteal bypass opera-
tions. The flow measurements are categorized as hundreds of
milliliters per minute, rounding off downwards.off, but no association was revealed.DISCUSSION
We aimed to investigate the predictive value of intraop-
erative transit-time flow measurements on primary assisted
patency in above-knee prosthetic femoropopliteal bypass.
Transit-time flow measurement has been demonstrated to
be a reliable method with reproducible results.7-9 Blood
flow in prostheses can only be measured indirectly with this
method, however, by measuring inflow or outflow in the
adjacent arteries. This is due to the attenuation of Doppler
signals in the prosthesis wall.
Outflow can be measured by placing the probe distally
to the reconstruction, which was done in most cases in the
present study. Inflow can be measured likewise by placing
the probe proximally to the reconstruction. In this study,
this was done in cases with technical difficulties by placing
the probe around the popliteal artery. In these patients, the
profunda femoral artery was clamped while flow was mea-
sured in the common femoral artery. If a proximal part of
the superficial femoral artery was open, a higher flow vol-
ume than the actual graft flow may have been recorded.
Likewise, flow measurements in the popliteal artery may
not have reflected the actual flow volume in the femoro-
popliteal graft. Because the anastomoses in the present
series were created end-to-side, some degree of retrograde
flow from the popliteal artery may have occurred in some
patients. If this was the case, the recorded flow was lower
than the actual graft flow.
Intraoperative Duplex ultrasound scans can also be
used to indirectly measure graft volume flow. One of the
main advantages with this method is visualization of the
reconstruction, which may detect technical errors. Other
advantages are that systolic and diastolic velocities may be
measured. Low end-diastolic velocities have been reported
to be associated with early graft failure in infragenicular vein
bypass.10 The main disadvantages of Duplex ultrasound
Fig 3. The distribution of papaverine flow measurements in 87
operations. The flowmeasurements are categorized as hundreds of
milliliters per minute, rounding off downwards.imaging are its complexity and user-dependent results.
ared
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construction and run-off but gives little information of
flow. Flow measurement has been reported to be a better
predictor of outcome than angiography.5 Angiography
may detect operative technical errors, however.
Lundell and Bergqvist1 reported that increased periph-
eral resistance was more predictive for early graft occlusion
then flow measurements. In the present study, peripheral
resistance was not estimated; however, the increase in pa-
paverine flow was caused by a reduced peripheral resis-
tance.11 In patients with extensive peripheral atherosclero-
sis, a lesser increase in papaverine flow may be expected
compared with patients with good run-off. However, we
did not find such an association between run-off score and
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Fig 4. The primary patency rates of 59 grafts with a papaverine
flow 500 mL/min and 28 grafts with a papaverine flow 500
mL/min. The numbers above and below the curves indicate the
numbers at risk. The differences in patency rates are significant
(P  .03, log-rank test). The median patency (time to reach 50%
occlusion rate) for grafts with papaverine flow500mL/min is 48
months (SEM, 6.7; 95% confidence interval, 35 to 61). The
median patency for grafts with papaverine flow 500 mL/min is
30 months (SEM, 4.3; 95% confidence interval, 21 to 38).
Table II. Primary assisted patency for 87 above-knee pros
Variables 30 days (%) 6 months (%)
Papaverine flow
500 mL/min 89 69
500 mL/min 94 86
Smoking
Smokers 94 70
Nonsmokers 97 85
Run-off score
1 crural artery 94 66
1 crural artery 97 86
Degree of ischemia
Critical 94 69
Claudication 97 81
The variables listed were analyzed with the product-limit method and comp
*Log-rank.measured flow. A possible reason for this may be thepresence of extensive collateral vessels in patients with poor
main run-off vessels. Furthermore, crural arteries classified
as patent on angiography may be occluded distally with
poor collateral flow to the foot, leading to high peripheral
resistance.
Epidural anesthesia has been reported to reduce pe-
ripheral resistance owing to a reduction of the sympathetic
vasomotor tone.12 The level of epidural anesthesia has been
shown to influence the increase in flow: a low level of
anesthesia leading to a larger flow increase than a high
level.13 The levels of epidural anesthesia given were not
recorded in the present study, and we were therefore not
able to evaluate these findings. Peripheral resistance may
also be altered by drugs administered intravenously during
surgery, such as dopamine or ephedrine.
A low increase in flow after the papaverine injection
indicates a high peripheral resistance.11 In this study, flow
increase showed no impact on patency, as it seems the
relative increase in flow after papaverine injection has less
influence on the fate of the graft compared with the abso-
lute papaverine flow value.
The heparin dosage during clamping was 5000 IU for
each patient. This is in agreement with established practice
in Scandinavia. A subtherapeutic dosage may have been
c femoropopliteal bypass operations
2 months (%) 2 years (%) 5 years (%) P*
58 48 18
83 66 52 .03
57 44 18
73 69 54 .03
57 42 27
83 66 31 .09
59 45 24
78 61 36 .52
with the log-rank test.
Table III. Multivariate analysis (Cox proportional
hazard model) of risk factors in 87 above-knee prosthetic
femoropopliteal bypass operations*
Variables  SE P HR 95% CI
Papaverine flow
500 mL/min 0.959 0.382 0.012 2.609 1.233-5.521
Smoking 1.014 0.383 0.008 2.757 1.301-5.843
Poor run-off
score† 0.868 0.334 0.009 2.383 1.239-4.582
SE, Standard error; HR, hazard ratio; CI, confidence interval.
*These risk factors were demonstrated with univaariate analysis to be nearly
significantly associated with patency rates (P  .1).
†Defined as 1 patent crural artery as seen on the preoperative angiogram.theti
1given in some cases, however, especially in obese patients.
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ministered.
The overall patency rates in the present series are com-
parable to or somewhat lower than those reported be-
fore.14-18 There were no differences in the distribution of
risk factors or flow values among the early occluders and
those that stayed open 1 and 3 months after surgery. It
was previously reported that early occlusion most often is
caused by operative technical errors or inappropriate selec-
tion of patients for surgery.19 The former could not be
shown in the present series because no intraoperative visu-
alization with Duplex or angiography was done.
Smokers had significantly lower patency rates than non-
smokers. This is in agreement with previous reports.20,21 A
recently published meta-analysis demonstrated a threefold
increase in graft failure for smokers compared with non-
smokers.22 It has been assumed that most graft occlusions
occur during the first postoperative year. This was the case
for nonsmokers in the present series. The grafts in smokers
continued to occlude beyond the first year, and the differ-
ence in patency between smokers and nonsmokers in our
series increased with time (Table II). This difference may be
due to an accelerated atherosclerosis in smokers. It also
underlines that a long observation time is necessary to
achieve a full overview. Because smoking is a modifiable risk
factor, smokers who are candidates for bypass surgery
should be informed of the magnitude of this risk factor
before surgery.
Poor run-off score was significantly correlated with
reduced patency rates, which is in accordance with previous
reports.16,18 Renal failure has previously been reported to
be associated with reduced patency rates.23,24 This was not
the case in the present study, probably because of small
numbers. Diabetes mellitus has also been reported to be
associated with reduced patency rates,25 whereas others
have reported no such association.26 In the present study,
no association between diabetes mellitus and reduced pa-
tency was found; however, the number of patients was small
and may not have been sufficient to achieve statistically
significant differences. This may also be the reason for the
similar results in patients with critical ischemia and inter-
mittent claudication.
When flow values lower than expected are measured
intraoperatively, the reconstruction should be visualized
with either angiography or Duplex ultrasound scan to
exclude operative technical errors. Because grafts with low
papaverine flow have an increased tendency to occlude,
frequent follow-up may be useful; however, it has not been
proven that graft surveillance increases patency. In the
present series, follow-up was annually beyond 1 year post-
operatively. Many grafts with low papaverine flow occluded
later than 1 year after surgery. If stenotic inflow or outflow
lesions had been detected and treated in some patients, this
might have improved patency rates.
Adjunctive antithrombotic medication is recommended.
Clopidogrel should be given to all patients with aspirin intol-
erance regardless of flow values, because antiplatelet agents
improve graft patency, especially in prosthetic grafts.27 Clopi-dogrel may add some effect to aspirin in patients with low
papaverine flow, but this has not been proven in controlled
trials. Warfarin has been reported to have an effect in
preventing occlusion in infrainguinal vein grafts, but not in
preventing prosthetic graft thrombosis.28
CONCLUSION
Intraoperative papaverine flow measurements predict
mid- and long-term patency of above-knee prosthetic fem-
oropopliteal bypass, whereas basal flowmeasurements yield
no predictive information. In this study, flow measurement
values could not be related to the preoperative angio-
graphic run-off score. The inferior patency rates of smokers
as well as patients with a poor run-off score indicate that
alternative treatments may be more suitable for these
groups of patients. In patients with low papaverine flow,
additional antithrombotic medication and frequent follow-
up should be considered.
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